This site is intended for US residents only.
(cabotegravir 200 mg/mL; rilpivirine 300 mg/mL)
extended-release injectable suspensions
All CABENUVA Events See full Prescribing Information for CABENUVA.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Trademarks are owned by or licensed to the ViiV Healthcare group of companies. This site is funded and developed by ViiV Healthcare. This site is intended for US residents only. ©2021 ViiV Healthcare or licensor. CBRWCNT210017 July 2021 Produced in USA.